Average Insider

Where insiders trade, we follow

ADARx Pharmaceuticals, Inc. ($ADRX)
Accession: 0000947871-26-000910
Sep 30, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$18.50
Current$19.9430.6% above low, 69.4% below high
52W High$23.21

Filing Information

Accession Number0000947871-26-000910
Form Type4
Filing DateSep 30, 2026
DocumentView SEC Filing
Transactions
19
Total Shares
47,461,578
Total Value
$16,150,000.00
P&L
+17.3% (+$2,793,000.00)

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
ORBIMED ADVISORS LLC
Director
Common Stock
โ€”Sep 28, 2026Conversion10,690,530โ€”โ€”10,690,530IndirectSee footnotesView Details
ORBIMED ADVISORS LLC
Director
Common Stock
โ€”Sep 28, 2026Conversion2,000,962โ€”โ€”12,691,492IndirectSee footnotesView Details
ORBIMED ADVISORS LLC
Director
Common Stock
โ€”Sep 28, 2026Conversion769,601โ€”โ€”13,461,093IndirectSee footnotesView Details
ORBIMED ADVISORS LLC
Director
Common Stock
โ€”Sep 28, 2026Conversion564,187โ€”โ€”14,025,280IndirectSee footnotesView Details
ORBIMED ADVISORS LLC
Director
Common Stock
โ€”Sep 28, 2026Purchase300,249$17.00$5,104,233.0014,325,529IndirectSee footnotesView Details
ORBIMED ADVISORS LLC
Director
Common Stock
โ€”Sep 28, 2026Conversion7,127,019โ€”โ€”7,127,019IndirectSee footnotesView Details
ORBIMED ADVISORS LLC
Director
Common Stock
โ€”Sep 28, 2026Conversion1,333,975โ€”โ€”8,460,994IndirectSee footnotesView Details
ORBIMED ADVISORS LLC
Director
Common Stock
โ€”Sep 28, 2026Conversion513,067โ€”โ€”8,974,061IndirectSee footnotesView Details
ORBIMED ADVISORS LLC
Director
Common Stock
โ€”Sep 28, 2026Conversion256,448โ€”โ€”9,230,509IndirectSee footnotesView Details
ORBIMED ADVISORS LLC
Director
Common Stock
โ€”Sep 28, 2026Purchase61,516$17.00$1,045,772.009,292,025IndirectSee footnotesView Details
ORBIMED ADVISORS LLC
Director
Common Stock
โ€”Sep 28, 2026Purchase588,235$17.00$9,999,995.00588,235IndirectSee footnotesView Details
ORBIMED ADVISORS LLC
Director
Series A Preferred Stock
(Common Stock)
DerivativeSep 28, 2026Conversion10,690,530$0.00$0.000IndirectSee footnotesView Details
ORBIMED ADVISORS LLC
Director
Series B Preferred Stock
(Common Stock)
DerivativeSep 28, 2026Conversion2,000,962$0.00$0.000IndirectSee footnotesView Details
ORBIMED ADVISORS LLC
Director
Series B-1 Preferred Stock
(Common Stock)
DerivativeSep 28, 2026Conversion769,601$0.00$0.000IndirectSee footnotesView Details
ORBIMED ADVISORS LLC
Director
Series C Preferred Stock
(Common Stock)
DerivativeSep 28, 2026Conversion564,187$0.00$0.000IndirectSee footnotesView Details
ORBIMED ADVISORS LLC
Director
Series A Preferred Stock
(Common Stock)
DerivativeSep 28, 2026Conversion7,127,019$0.00$0.000IndirectSee footnotesView Details
ORBIMED ADVISORS LLC
Director
Series B Preferred Stock
(Common Stock)
DerivativeSep 28, 2026Conversion1,333,975$0.00$0.000IndirectSee footnotesView Details
ORBIMED ADVISORS LLC
Director
Series B-1 Preferred Stock
(Common Stock)
DerivativeSep 28, 2026Conversion513,067$0.00$0.000IndirectSee footnotesView Details
ORBIMED ADVISORS LLC
Director
Series C Preferred Stock
(Common Stock)
DerivativeSep 28, 2026Conversion256,448$0.00$0.000IndirectSee footnotesView Details
Version: v26.10.3